N1C=CC=CC=1.[CH2:7]([CH:9]([CH2:13][CH3:14])[C:10](Cl)=[O:11])[CH3:8].[F:15][C:16]([F:50])([F:49])[C:17]1[CH:18]=[C:19]([CH:42]=[C:43]([C:45]([F:48])([F:47])[F:46])[CH:44]=1)[CH2:20][N:21]([C@@H:28]1[C:34]2=[CH:35][C:36]3[CH2:37][O:38][CH2:39][C:40]=3[CH:41]=[C:33]2[NH:32][CH2:31][CH2:30][CH2:29]1)[C:22]1[N:23]=[N:24][N:25]([CH3:27])[N:26]=1.O>ClCCl>[F:50][C:16]([F:15])([F:49])[C:17]1[CH:18]=[C:19]([CH:42]=[C:43]([C:45]([F:46])([F:47])[F:48])[CH:44]=1)[CH2:20][N:21]([C:22]1[N:23]=[N:24][N:25]([CH3:27])[N:26]=1)[C@@H:28]1[C:34]2=[CH:35][C:36]3[CH2:37][O:38][CH2:39][C:40]=3[CH:41]=[C:33]2[N:32]([C:10](=[O:11])[CH:9]([CH2:13][CH3:14])[CH2:7][CH3:8])[CH2:31][CH2:30][CH2:29]1Add pyridine (0.35 mmol) followed by 2-ethyl-butyryl chloride (0.35 mmol) to a solution of (S)-(3,5-Bis-trifluoromethyl-benzyl)-(3,5,6,7,8,9-hexahydro-1H-2-oxa-5-aza-cyclohepta[f]inden-9-yl)-(2-methyl-2H-tetrazol-5-yl)-amine (Example 73, Step 7) (0.17 mmol) in dichloromethane (3 mL). After stirring at room temperature for 14 h, dilute the reaction with dichloromethane (10 mL) followed by water (10 mL). Separate the organic phase and wash the aqueous with dichloromethane (2×10 mL). Dry the combined organics over sodium sulfate, filter, and remove solvent in vacuo. Chromatograph the crude product over silica gel using ethyl acetate/hexane (10-50%) to elute to obtain the title compound as a colorless foam. MS (ES+): 611 (M+H).